首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1933282

全球合約生產組織 (CRO) 市場：市場規模、市場佔有率、成長率、行業分析、依類型、應用和地區劃分的考慮因素以及未來預測 (2026-2034)

Contract Manufacturing Organization Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

出版日期: 2026年01月12日 | 出版商:

Fortune Business Insights Pvt. Ltd. | 英文 107 Pages | 商品交期: 請詢問到貨日

價格

簡介目錄圖表

合約生產組織 (CRO) 市場的成長因素

全球合約生產組織 (CRO) 市場在醫藥和生技供應鏈中扮演著至關重要的角色，它使企業能夠將藥品生產業務外包，從而專注於研發和商業化等核心活動。合約生產組織 (CMO) 提供廣泛的服務，包括活性藥物成分 (API)、製劑開發、穩定性測試、包裝和商業化生產，同時確保符合嚴格的監管標準，例如良好生產規範 (GMP)。

根據這份報告，全球合約生產組織 (CRO) 市場預計到 2025 年將達到 1,682.4 億美元。預計到 2026 年，該市場將成長至 1,812.9 億美元，到 2034 年將達到 3,412.3 億美元，預測期內複合年增長率 (CAGR) 為 8.1%。北美在 2025 年引領全球市場，佔市場佔有率的 31.90%。這主要得益於其強大的生物製藥生產基礎設施以及先進療法和生物製品外包業務的不斷增長。

合約生產組織 (CRO) 市場趨勢

影響 CMO 市場發展的關鍵趨勢之一是生產流程中數位化和自動化程度的不斷提高。 CMO 正在整合先進的數位技術、人工智慧和自動化生產系統，以提高效率、改善品質控制並降低營運風險。

向數位化和自動化無菌生產的轉變正在加速發展，這種轉變能夠實現無紙化操作、增強可追溯性並更快地識別品質偏差。這一趨勢有助於提高整體設備效率 (OEE)，同時加強對監管標準的遵守。此外，CMO 正在擴展其端到端生產解決方案，以應對現代藥物開發日益複雜的挑戰。

市場成長驅動因素

生物製劑和生物相似藥生產外包的增加是推動 CRO（合約生產組織）市場成長的主要因素。全球慢性疾病負擔日益加重，例如癌症、糖尿病和神經系統疾病，這加速了對複雜生物製劑的需求，而這些生物製劑需要專門的生產技術和基礎設施。

製藥公司越來越多地與合約生產組織 (CMO) 合作，以經濟高效且可擴展的方式生產生物製劑和生物類似藥。此外，對個人化醫療和基因療法的日益關注也為擁有先進能力的 CMO 創造了新的機會。

另一個主要的成長驅動因素是 CMO 加大對擴大其製藥生產能力的投資。為了滿足不斷增長的全球需求，CMO 正在大力投資新建工廠、擴大產能、開發連續生產流程和先進的分析技術。這些投資使 CMO 能夠提供貫穿整個藥物生命週期的綜合服務，從而推動市場的長期成長。

限制因子

儘管成長前景強勁，但市場仍存在一些挑戰。建立和擴大製藥生產設施的高昂成本是一個主要的限制因素。新建生產設施需要大量資本投資、漫長的建設週期以及嚴格的監管批准。

此外，由於擔心產品品質、資料安全和供應鏈依賴性，製藥公司可能不願意完全依賴合約生產組織 (CMO) 進行關鍵的生產營運。這些因素可能會限制新進入者的進入，並阻礙某些地區的市場擴張。

合約生產組織 (CRO) 市場：細分市場分析

依服務類型，市場可分為三個部分：原料藥生產、成品藥生產、包裝。原料藥生產部分佔市場主導地位，預計到 2026 年將達到 54.28% 的市場佔有率，這主要得益於為提高成本效益和營運靈活性而增加的原料藥生產外包。

成品藥部分佔第二大市場佔有率，這主要得益於對固體製劑和注射劑的需求不斷增長，尤其是在新興市場。包裝領域佔適中的市場佔有率，這主要得益於合約生產商 (CMO) 越來越多地提供整合包裝解決方案，以確保產品及時交付。

區域洞察

北美仍是領先地區，憑藉對生物製藥生產的積極投資和戰略聯盟，預計到 2026 年市場規模將達到 574.5 億美元。歐洲由於主要 CMO 的存在以及原料藥生產設施的擴張，預計到 2026 年也將佔相當大的市場佔有率。

亞太地區已成為成長最快的地區，這得益於醫療基礎設施的改善、藥品出口的成長以及中國、日本和印度等國本土製藥企業的崛起。

主要參與者趨勢

市場高度分散，主要參與者包括 Lonza、Catalent、Thermo Fisher Scientific、三星生物製劑和無錫生物製劑。這些公司正致力於擴大生產能力、建立策略合作夥伴關係並加強服務，以增強其全球影響力。

The global Contract Manufacturing Organizations (CMO) market plays a vital role in the pharmaceutical and biotechnology supply chain by enabling companies to outsource drug manufacturing activities and focus on core functions such as research, development, and commercialization. CMOs offer a wide range of services including API manufacturing, formulation development, stability testing, packaging, and commercial-scale production, while ensuring compliance with strict regulatory standards such as Good Manufacturing Practices (GMP).

According to the report, the global Contract Manufacturing Organizations (CMO) market size was valued at USD 168.24 billion in 2025. The market is projected to grow to USD 181.29 billion in 2026 and further reach USD 341.23 billion by 2034, registering a CAGR of 8.1% during the forecast period. North America dominated the global market in 2025, accounting for 31.90% market share, supported by strong biopharmaceutical manufacturing infrastructure and rising outsourcing of advanced therapies and biologics.

Contract Manufacturing Organizations (CMO) Market Trends

One of the major trends shaping the CMO market is the increasing adoption of digitization and automation in manufacturing processes. CMOs are integrating advanced digital technologies, artificial intelligence, and automated production systems to enhance efficiency, improve quality control, and reduce operational risks.

The shift toward digitalized and automated aseptic manufacturing is gaining momentum, as it enables paperless operations, improved traceability, and faster identification of quality deviations. This trend is strengthening compliance with regulatory standards while improving overall equipment effectiveness (OEE). Additionally, CMOs are increasingly offering end-to-end manufacturing solutions to meet the growing complexity of modern drug development.

Market Growth Factors

The rising outsourcing of biologics and biosimilars manufacturing is a key driver of the Contract Manufacturing Organizations (CMO) market growth. The increasing global burden of chronic diseases such as cancer, diabetes, and neurological disorders has accelerated the demand for complex biologics, which require specialized manufacturing expertise and infrastructure.

Pharmaceutical companies are increasingly partnering with CMOs to manufacture biologics and biosimilars in a cost-effective and scalable manner. Moreover, the growing focus on personalized medicine and gene therapies is creating new opportunities for CMOs with advanced capabilities.

Another major growth factor is the increasing investment by CMOs in expanding their drug manufacturing capacity. To meet rising global demand, CMOs are investing heavily in new facilities, capacity expansion, continuous manufacturing processes, and advanced analytical technologies. These investments enable CMOs to offer integrated services across the drug lifecycle, driving long-term market growth.

Restraining Factors

Despite strong growth prospects, the market faces certain challenges. High costs associated with establishing and expanding pharmaceutical manufacturing facilities act as a major restraint. Building a new production facility requires substantial capital investment, long timelines, and strict regulatory approvals.

Additionally, pharmaceutical companies may hesitate to fully rely on CMOs for critical manufacturing operations due to concerns related to product quality, data security, and supply chain dependency. These factors can limit the entry of new players and restrict market expansion in certain regions.

Contract Manufacturing Organizations (CMO) Market Segmentation Analysis

Based on service, the market is segmented into API manufacturing, finished product manufacturing, and packaging. The API manufacturing segment dominated the market with a 54.28% share in 2026, driven by the increasing outsourcing of API production to achieve cost efficiency and operational flexibility.

The finished product segment held the second-largest share, supported by growing demand for solid dosage forms and injectables, particularly in emerging markets. The packaging segment accounted for a moderate share, as CMOs increasingly provide integrated packaging solutions to ensure timely product delivery.

Regional Insights

North America remained the leading region, with a market value of USD 57.45 billion in 2026, driven by strong investments in biologics manufacturing and strategic collaborations. Europe accounted for a significant market share in 2026, supported by the presence of major CMOs and expansion of API production facilities.

Asia Pacific emerged as the fastest-growing region due to improving healthcare infrastructure, rising pharmaceutical exports, and increasing number of domestic drug manufacturers in countries such as China, Japan, and India.

Key Industry Players

The market is highly fragmented, with key players including Lonza, Catalent, Inc., Thermo Fisher Scientific Inc., Samsung Biologics, and WuXi Biologics. These companies focus on expanding manufacturing capacities, forming strategic partnerships, and enhancing service offerings to strengthen their global presence.

Conclusion

The global Contract Manufacturing Organizations (CMO) market is set to experience sustained growth through 2034, driven by increasing outsourcing of pharmaceutical manufacturing, rising demand for biologics and biosimilars, and continuous investments in advanced manufacturing technologies. While high capital requirements and regulatory complexities pose challenges, expanding healthcare needs, technological advancements, and strategic collaborations are expected to support long-term market expansion and maintain positive growth momentum over the forecast period.

Segmentation By Service

API Manufacturing
Finished Product
- Solid Dosage Forms
- Injectables
- Others
Packaging

By Region

North America (By Service and Country)
- U.S.
- Canada
Europe (By Service and Country/Sub-region)
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Service and Country/Sub-region)
- India
- China
- Japan
- Australia
- Rest of Asia Pacific
Rest of the World (By Service)

Table of Content

1. Introduction

1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends

4. Key Insights

4.1. Technological Advancements in Contract Manufacturing Organizations (CMO) Market
4.2. Overview of Regulatory Scenario, By Key Countries/Region
4.3. Key Industry Developments Mergers, Acquisitions, Partnerships, etc.
4.4. Impact of COVID-19 on the Market

5. Global Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

5.1. Market Analysis, Insights and Forecast - By Service
- 5.1.1. API Manufacturing
- 5.1.2. Finished Product
  - 5.1.2.1. Solid Dosage Forms
  - 5.1.2.2. Injectables
  - 5.1.2.3. Others
- 5.1.3. Packaging
5.2. Market Analysis, Insights and Forecast - By Region
- 5.2.1. North America
- 5.2.2. Europe
- 5.2.3. Asia Pacific
- 5.2.4. Rest of the World

6. North America Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

6.1. Market Analysis, Insights and Forecast - By Service
- 6.1.1. API Manufacturing
- 6.1.2. Finished Product
  - 6.1.2.1. Solid Dosage Forms
  - 6.1.2.2. Injectables
  - 6.1.2.3. Others
- 6.1.3. Packaging
6.2. Market Analysis, Insights and Forecast - By Country
- 6.2.1. U.S.
- 6.2.2. Canada

7. Europe Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

7.1. Market Analysis, Insights and Forecast - By Service
- 7.1.1. API Manufacturing
- 7.1.2. Finished Product
  - 7.1.2.1. Solid Dosage Forms
  - 7.1.2.2. Injectables
  - 7.1.2.3. Others
- 7.1.3. Packaging
7.2. Market Analysis, Insights and Forecast - By Countries/Sub-region
- 7.2.1. Germany
- 7.2.2. France
- 7.2.3. U.K.
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Scandinavia
- 7.2.7. Rest of the Europe

8. Asia Pacific Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

8.1. Market Analysis, Insights and Forecast - By Service
- 8.1.1. API Manufacturing
- 8.1.2. Finished Product
  - 8.1.2.1. Solid Dosage Forms
  - 8.1.2.2. Injectables
  - 8.1.2.3. Others
- 8.1.3. Packaging
8.2. Market Analysis, Insights and Forecast - By Countries/Sub-region
- 8.2.1. China
- 8.2.2. Japan
- 8.2.3. India
- 8.2.4. Australia
- 8.2.5. Rest of Asia Pacific

9. Rest of the World Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

9.1. Market Analysis, Insights and Forecast - By Service
- 9.1.1. API Manufacturing
- 9.1.2. Finished Product
  - 9.1.2.1. Solid Dosage Forms
  - 9.1.2.2. Injectables
  - 9.1.2.3. Others
- 9.1.3. Packaging

10. Competitive Analysis

10.1. Global Market Share Analysis (2025)
10.2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 10.2.1. Boehringer Ingelheim International GmbH
  - 10.2.1.1. Overview
  - 10.2.1.2. Services
  - 10.2.1.3. SWOT Analysis
  - 10.2.1.4. Recent Developments
  - 10.2.1.5. Strategies
  - 10.2.1.6. Financials (Based on Availability)
- 10.2.2. Almac Group
  - 10.2.2.1. Overview
  - 10.2.2.2. Services
  - 10.2.2.3. SWOT Analysis
  - 10.2.2.4. Recent Developments
  - 10.2.2.5. Strategies
  - 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Recipharm AB
  - 10.2.3.1. Overview
  - 10.2.3.2. Services
  - 10.2.3.3. SWOT Analysis
  - 10.2.3.4. Recent Developments
  - 10.2.3.5. Strategies
  - 10.2.3.6. Financials (Based on Availability)
- 10.2.4. Dr. Reddy's Laboratories Ltd.
  - 10.2.4.1. Overview
  - 10.2.4.2. Services
  - 10.2.4.3. SWOT Analysis
  - 10.2.4.4. Recent Developments
  - 10.2.4.5. Strategies
  - 10.2.4.6. Financials (Based on Availability)
- 10.2.5. FAMAR Health Care Services
  - 10.2.5.1. Overview
  - 10.2.5.2. Services
  - 10.2.5.3. SWOT Analysis
  - 10.2.5.4. Recent Developments
  - 10.2.5.5. Strategies
  - 10.2.5.6. Financials (Based on Availability)
- 10.2.6. Lonza
  - 10.2.6.1. Overview
  - 10.2.6.2. Services
  - 10.2.6.3. SWOT Analysis
  - 10.2.6.4. Recent Developments
  - 10.2.6.5. Strategies
  - 10.2.6.6. Financials (Based on Availability)
- 10.2.7. Vetter Pharma-Fertigung GmbH & Co. KG
  - 10.2.7.1. Overview
  - 10.2.7.2. Services
  - 10.2.7.3. SWOT Analysis
  - 10.2.7.4. Recent Developments
  - 10.2.7.5. Strategies
  - 10.2.7.6. Financials (Based on Availability)
- 10.2.8. Jubilant Pharmova Limited
  - 10.2.8.1. Overview
  - 10.2.8.2. Services
  - 10.2.8.3. SWOT Analysis
  - 10.2.8.4. Recent Developments
  - 10.2.8.5. Strategies
  - 10.2.8.6. Financials (Based on Availability)
- 10.2.9. Catalent Inc.
  - 10.2.9.1. Overview
  - 10.2.9.2. Services
  - 10.2.9.3. SWOT Analysis
  - 10.2.9.4. Recent Developments
  - 10.2.9.5. Strategies
  - 10.2.9.6. Financials (Based on Availability)

簡介目錄圖表

List of Tables

Table 1: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
Table 2: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Finished Product, 2021-2034
Table 3: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Region, 2021-2034
Table 4: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
Table 5: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
Table 6: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country, 2021-2034
Table 7: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
Table 8: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
Table 9: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
Table 10: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
Table 11: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
Table 12: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
Table 13: Rest of the World Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
Table 14: Rest of the World Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034

List of Figures

Figure 1: Global Contract Manufacturing Organizations (CMO) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
Figure 2: Global Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025 & 2034
Figure 3: Global Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Region, 2025 & 2034
Figure 4: North America Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
Figure 5: North America Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
Figure 6: North America Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country, 2025 & 2034
Figure 7: North America Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country, 2025
Figure 8: Europe Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
Figure 9: Europe Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
Figure 10: Europe Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
Figure 11: Europe Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country/ Sub-region, 2025
Figure 12: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
Figure 13: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
Figure 14: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
Figure 15: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country/ Sub-region, 2025
Figure 16: Rest of the World Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
Figure 17: Rest of the World Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
Figure 18: Global Contract Manufacturing Organization (CMO) Market Share (%), By Company, 2025